HuGE Literature Finder
Records
1
-
30
| Urinary bisphenol A and its interaction with CYP17A1 rs743572 are associated with breast cancer risk. Chemosphere 2021 Aug 286 (Pt 3): 131880. He Heng, Deng Yao, Wan Hao, Shen Na, Li Jiaoyuan, Zeng Qiang, Chang Jiang, Lu Qing, Miao Xiaoping, Tian Jianbo, Zhong Ro |
| CYP17A1 polymorphism c.-362T>C predicts clinical outcome in metastatic castration-resistance prostate cancer patients treated with abiraterone. Cancer chemotherapy and pharmacology 2020 Sep . Crucitta Stefania, Del Re Marzia, Paolieri Federico, Bloise Francesco, Sbrana Andrea, Sammarco Enrico, Mercinelli Chiara, Cucchiara Federico, Fontanelli Lorenzo, Galli Luca, Danesi Roma |
| Evaluation of CYP17A1 and CYP1B1 polymorphisms in male breast cancer risk. Endocrine connections 2019 Jul . Rizzolo Piera, Silvestri Valentina, Valentini Virginia, Zelli Veronica, Bucalo Agostino, Zanna Ines, Bianchi Simonetta, Tibiletti Maria Grazia, Russo Antonio, Varesco Liliana, Tedaldi Gianluca, Bonanni Bernardo, Azzollini Jacopo, Manoukian Siranoush, Coppa Anna, Giannini Giuseppe, Cortesi Laura, Viel Alessandra, Montagna Marco, Peterlongo Paolo, Radice Paolo, Palli Domenico, Ottini Lau |
| Genetic Variations, Exposure to Persistent Organic Pollutants and Breast Cancer Risk - A Greenlandic Case-Control Study. Basic & clinical pharmacology & toxicology 2018 Mar . Wielsøe Maria, Eiberg Hans, Ghisari Mandana, Kern Peder, Lind Ole, Bonefeld-Jørgensen Eva Cecil |
| Associations between polymorphisms in genes related to estrogen metabolism and function and prostate cancer risk: results from the Prostate Cancer Prevention Trial. Carcinogenesis 2017 Dec . Tang Li, Platek Mary E, Yao Song, Till Cathee, Goodman Phyllis J, Tangen Catherine M, Wu Yue, Platz Elizabeth A, Neuhouser Marian L, Stanczyk Frank Z, Reichardt Juergen K V, Santella Regina M, Hsing Ann, Figg William D, Lippman Scott M, Thompson Ian M, Ambrosone Christine |
| Pharmacogenetics and aromatase inhibitor induced side effects in breast cancer patients. Pharmacogenomics 2017 Jun . Sini Valentina, Botticelli Andrea, Lunardi Gianluigi, Gori Stefania, Marchetti Pao |
| Polymorphism in xenobiotic and estrogen metabolizing genes, exposure to perfluorinated compounds and subsequent breast cancer risk: A nested case-control study in the Danish National Birth Cohort. Environmental research 2017 Jan 154 325-333. Ghisari Mandana, Long Manhai, Røge Durita Mohr, Olsen Jørn, Bonefeld-Jørgensen Eva |
| Association between polymorphisms in sex hormones synthesis and metabolism and prostate cancer aggressiveness. PloS one 2017 12 (10): e0185447. Robles-Fernandez Inmaculada, Martinez-Gonzalez Luis Javier, Pascual-Geler Manrique, Cozar Jose Manuel, Puche-Sanz Ignacio, Serrano Maria Jose, Lorente Jose Antonio, Alvarez-Cubero Maria Jes |
| CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone. The International journal of biological markers 2016 Feb 0. Salvi Samanta, Casadio Valentina, Burgio Salvatore Luca, Conteduca Vincenza, Rossi Lorena, Menna Cecilia, Carretta Elisa, Costantini Matteo, Zoli Wainer, Giorgi Ugo |
| Association of the CYP17-34T/C Polymorphism with Pancreatic Cancer Risk. Asian Pacific journal of cancer prevention : APJCP 2016 17 Spec No. 71-5. Hussain Shahid, Bano Raisa, Tahir Khan Muhammad, Haroon Khan Mohamm |
| Common Genetic Variation in CYP17A1 and Response to Abiraterone Acetate in Patients with Metastatic Castration-Resistant Prostate Cancer. International journal of molecular sciences 2016 17 (7): . Binder Moritz, Zhang Ben Y, Hillman David W, Kohli Rhea, Kohli Tanvi, Lee Adam, Kohli Mani |
| CYP11A1 expression in bone is associated with aromatase inhibitor-related bone loss. Journal of molecular endocrinology 2015 Aug 55 (1): 69-79. Rodríguez-Sanz M, García-Giralt N, Prieto-Alhambra D, Servitja S, Balcells S, Pecorelli R, Díez-Pérez A, Grinberg D, Tusquets I, Nogués |
| Genetic variations in genes involved in testosterone metabolism are associated with prostate cancer progression: A Spanish multicenter study. Urologic oncology 2015 Jul 33 (7): 331.e1-7. Henríquez-Hernández Luis Alberto, Valenciano Almudena, Foro-Arnalot Palmira, Álvarez-Cubero María Jesús, Cozar José Manuel, Suárez-Novo José Francisco, Castells-Esteve Manel, Fernández-Gonzalo Pablo, De-Paula-Carranza Belén, Ferrer Montse, Guedea Ferrán, Sancho-Pardo Gemma, Craven-Bartle Jordi, Ortiz-Gordillo María José, Cabrera-Roldán Patricia, Rodríguez-Melcón Juan Ignacio, Herrera-Ramos Estefanía, Rodríguez-Gallego Carlos, Lara Pedro |
| Circulating cell-free AR and CYP17A1 copy number variations may associate with outcome of metastatic castration-resistant prostate cancer patients treated with abiraterone. British journal of cancer 2015 May 112 (10): 1717-24. Salvi S, Casadio V, Conteduca V, Burgio S L, Menna C, Bianchi E, Rossi L, Carretta E, Masini C, Amadori D, Calistri D, Attard G, De Giorgi |
| Genetic polymorphisms in the androgen metabolism pathway and risk of prostate cancer in low incidence Malaysian ethnic groups. International journal of clinical and experimental medicine 2015 8 (10): 19232-40. Poniah Prevathe, Mohamed Zahurin, Apalasamy Yamunah Devi, Mohd Zain Shamsul, Kuppusamy Shanggar, Razack Azad |
| Genetic polymorphisms of ESR1, ESR2, CYP17A1, and CYP19A1 and the risk of breast cancer: a case control study from North India. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2014 May 35 (5): 4517-27. Chattopadhyay Shilpi, Siddiqui Sarah, Akhtar Md Salman, Najm Mohammad Zeeshan, Deo S V S, Shukla N K, Husain Syed Akht |
| Polymorphisms in phase I and phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case-control study in Inuit women. Environmental health : a global access science source 2014 13 (1): 19. Ghisari Mandana, Eiberg Hans, Long Manhai, Bonefeld-Jørgensen Eva |
| CYP17A1 T-34C polymorphism is not associated with endometrial cancer risk. Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2013 Oct 34 (5): 2583-7. Yang Xueying, Feng Aihua, Liu Fengying, Li Qun, Zhang Jing, Yang Chuanhua, An Yuj |
| Genetic polymorphisms of CYP17A1 in steroidogenesis pathway are associated with risk of progression to castration-resistant prostate cancer in Japanese men receiving androgen deprivation therapy. International journal of clinical oncology 2013 Aug 18 (4): 711-7. Yamada Takeshi, Nakayama Masashi, Shimizu Tomohito, Nonen Shinpei, Nakai Yasutomo, Nishimura Kazuo, Fujio Yasushi, Okuyama Akihiko, Azuma Junichi, Nonomura Nor |
| Genetic determinants of aromatase inhibitor-related arthralgia: the B-ABLE cohort study. Breast cancer research and treatment 2013 Jul 140 (2): 385-95. Garcia-Giralt Natalia, Rodríguez-Sanz María, Prieto-Alhambra Daniel, Servitja Sonia, Torres-Del Pliego Elisa, Balcells Susana, Albanell Joan, Grinberg Daniel, Diez-Perez Adolfo, Tusquets Ignasi, Nogués Xavi |
| Menstrual and reproductive factors in women, genetic variation in CYP17A1, and pancreatic cancer risk in the European prospective investigation into cancer and nutrition (EPIC) cohort. International journal of cancer. Journal international du cancer 2013 May 132 (9): 2164-75. Duell Eric J, Travier Noémie, Lujan-Barroso Leila, Dossus Laure, Boutron-Ruault Marie-Christine, Clavel-Chapelon Françoise, Tumino Rosario, Masala Giovanna, Krogh Vittorio, Panico Salvatore, Ricceri Fulvio, Redondo Maria Luisa, Dorronsoro Miren, Molina-Montes Esther, Huerta José M, Barricarte Aurelio, Khaw Kay-Tee, Wareham Nick J, Allen Naomi E, Travis Ruth, Siersema Peter D, Peeters Petra H M, Trichopoulou Antonia, Fragogeorgi Eirini, Oikonomou Eleni, Boeing Heiner, Schuetze Madlen, Canzian Federico, Lukanova Annekatrin, Tjønneland Anne, Roswall Nina, Overvad Kim, Weiderpass Elisabete, Gram Inger Torhild, Lund Eiliv, Lindkvist Björn, Johansen Dorthe, Ye Weimin, Sund Malin, Fedirko Veronika, Jenab Mazda, Michaud Dominique S, Riboli Elio, Bueno-de-Mesquita H B |
| Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression. Clinical cancer research : an official journal of the American Association for Cancer Research 2013 Feb 19 (3): 699-709. Lévesque Éric, Huang Shu-Pin, Audet-Walsh Étienne, Lacombe Louis, Bao Bo-Ying, Fradet Yves, Laverdière Isabelle, Rouleau Mélanie, Huang Chao-Yuan, Yu Chia-Cheng, Caron Patrick, Guillemette Chant |
| Association between polymorphisms in COMT, PLCH1, and CYP17A1, and non-small-cell lung cancer risk in Chinese nonsmokers. Clinical lung cancer 2013 Jan 14 (1): 45-9. Zhang Yongjun, Hua Shi, Zhang Aiqin, Kong Xiangming, Jiang Chuming, Deng Dehou, Wenlong B |
| Androgen metabolism and JAK/STAT pathway genes and prostate cancer risk. Cancer epidemiology 2012 Aug 36 (4): 347-53. Kwon Erika M, Holt Sarah K, Fu Rong, Kolb Suzanne, Williams Gabrielle, Stanford Janet L, Ostrander Elaine |
| Estrogen-related genes and their contribution to racial differences in breast cancer risk. Cancer causes & control : CCC 2012 May 23 (5): 671-81. Reding Kerryn W, Chen Chu, Lowe Kimberly, Doody David R, Carlson Christopher S, Chen Christina T, Houck John, Weiss Linda K, Marchbanks Polly A, Bernstein Leslie, Spirtas Robert, McDonald Jill A, Strom Brian L, Burkman Ronald T, Simon Michael S, Liff Jonathan M, Daling Janet R, Malone Kathleen |
| Gender influences the class III and V ß-tubulin ability to predict poor outcome in colorectal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 2012 May 18 (10): 2964-75. Mariani Marisa, Zannoni Gian Franco, Sioletic Stefano, Sieber Steven, Martino Candice, Martinelli Enrica, Coco Claudio, Scambia Giovanni, Shahabi Shohreh, Ferlini Cristia |
| Genetic susceptibility factors on genes involved in the steroid hormone biosynthesis pathway and progesterone receptor for gastric cancer risk. PloS one 2012 7 (10): e47603. Cho Lisa Y, Yang Jae Jeong, Ko Kwang-Pil, Ma Seung Hyun, Shin Aesun, Choi Bo Youl, Han Dong Soo, Song Kyu Sang, Kim Yong Sung, Chang Soung-Hoon, Shin Hai-Rim, Kang Daehee, Yoo Keun-Young, Park Sue |
| Modification of menopausal hormone therapy-associated colorectal cancer risk by polymorphisms in sex steroid signaling, metabolism and transport related genes. Endocrine-related cancer 2011 Jun 18 (3): 371-84. Rudolph Anja, Sainz Juan, Hein Rebecca, Hoffmeister Michael, Frank Bernd, Försti Asta, Brenner Hermann, Hemminki Kari, Chang-Claude Jen |
| Estrogen and progesterone-related gene variants and colorectal cancer risk in women. BMC medical genetics 2011 12 (1): 78. Lin Jennifer H, Manson JoAnn E, Kraft Peter, Cochrane Barbara B, Gunter Marc J, Chlebowski Rowan T, Zhang Shumin |
| Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population. Asian journal of andrology 0 17 (2): 285-91. Han Jun Hyun, Lee Yong Seong, Kim Hae Jong, Lee Shin Young, Myung Soon Ch |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: